EPS Bio Technology Balance Sheet Health
Financial Health criteria checks 6/6
EPS Bio Technology has a total shareholder equity of NT$313.2M and total debt of NT$13.6M, which brings its debt-to-equity ratio to 4.4%. Its total assets and total liabilities are NT$565.1M and NT$251.9M respectively. EPS Bio Technology's EBIT is NT$33.7M making its interest coverage ratio -44. It has cash and short-term investments of NT$151.3M.
Key information
4.4%
Debt to equity ratio
NT$13.63m
Debt
| Interest coverage ratio | -44x |
| Cash | NT$151.32m |
| Equity | NT$313.21m |
| Total liabilities | NT$251.87m |
| Total assets | NT$565.09m |
Recent financial health updates
No updates
Recent updates
Should You Or Shouldn't You: A Dividend Analysis on EPS Bio Technology Corp. (GTSM:4183)
Apr 16
Will EPS Bio Technology (GTSM:4183) Multiply In Value Going Forward?
Mar 20Here's Why We Think EPS Bio Technology's (GTSM:4183) Statutory Earnings Might Be Conservative
Feb 22Do Fundamentals Have Any Role To Play In Driving EPS Bio Technology Corp.'s (GTSM:4183) Stock Up Recently?
Feb 01
Should EPS Bio Technology Corp. (GTSM:4183) Be Part Of Your Dividend Portfolio?
Jan 04Is EPS Bio Technology (GTSM:4183) Likely To Turn Things Around?
Dec 14We Think EPS Bio Technology's (GTSM:4183) Statutory Profit Might Understate Its Earnings Potential
Nov 23Financial Position Analysis
Short Term Liabilities: 4183's short term assets (NT$389.4M) exceed its short term liabilities (NT$142.2M).
Long Term Liabilities: 4183's short term assets (NT$389.4M) exceed its long term liabilities (NT$109.6M).
Debt to Equity History and Analysis
Debt Level: 4183 has more cash than its total debt.
Reducing Debt: 4183's debt to equity ratio has reduced from 9% to 4.4% over the past 5 years.
Debt Coverage: 4183's debt is well covered by operating cash flow (72.7%).
Interest Coverage: 4183 earns more interest than it pays, so coverage of interest payments is not a concern.